The Ultimate 1-Stop ELISA Marketplace:
60,000+ ELISA kits Available to Serve Scientists from All Fields of Life Science
Always Powered by Diagnocine for Precision Research.
Most comprehensive buffers, reagents and detection agents are provided with each kit to optimize data output.
All-inclusive format covers everything from sample preparation to signal detection. Every step can be customized and optimized for your precision research.
DiagnoCine Precision buffers and reagents are Made in USA ISO 13485 Certified
Why waste time searching for your ELISA kit when you can get everything in one place? Diagnocine can provide you with all the ELISA needs you have (customized ELISAs also available) on the planet through a single, streamlined ordering process.
* all types of species
* HRP and AP detection
* Low target signal enhancement
* Inquire about a trial version or a customized version
4 core reagents below are included with every order, plus 1 of the 2 detection-specific reagents (matched automatically to your kit type) — 5 components, every time.
+ the 5th component, matched to your kit's detection method:
If you have any questions or need additional information, please call us at 551-245-1033 or email us at support@diagnocine.com. Our team will be happy to assist you.
Universal Compatibility
All buffers and detection reagents work seamlessly across target proteins, bridging the gap in assay consistency.
1-Stop Convenience
Consolidate your lab's purchasing. Source all ELISA needs and experience optimal buffers and reagents in a single shipment.
Enhanced Precision
Designed by scientists for scientists, all components are engineered to deliver sharper results and an optical signal.
Human Interleukin 5,IL-5 ELISA KIT
Sandwich quantitative immunoassay for Human Interleukin 5,IL-5 ELISA KIT in human serum, plasma, tissue homogenates available in multiple catalog sizes:
Note: Please send inquiries regarding Trial 24T orders to support@diagnocine.com.
| Uniprot No. | P05113 |
| Species | Homo sapiens (Human) |
| Sample types | serum, plasma, tissue homogenates |
| Detection range | 3.9 pg/ml-250 pg/ml |
| Sensitivity | 0.97 pg/ml |
| Assay time | 1-5h |
| Sample loading volume | 50-100μL |
| Detection wavelength | 450 nm |
| Assay principle | Sandwich (Quantitative) |
| Data analysis | Standard curve + Curve Expert software |
| Research area | Immunology |
| Storage condition | 2-8°C (see protocol for full details) |
| Shipping condition | 4 °C |
| Shelf life | 6 months |
10 business days
Processing + 3-5 days shipping
In Stock : USA
Worldwide shipping available
Antibody capture
450 nm detection
Standard curve
Quantification
In this sandwich ELISA, Human Interleukin 5,IL-5 ELISA KIT in the sample is captured between a pre-coated capture antibody and a detection antibody. Signal intensity is proportional to analyte concentration. Quantification uses a standard curve fitted with Curve Expert software, covering 3.9 pg/ml-250 pg/ml with a minimum detectable dose of 0.97 pg/ml.
Interleukin-5 (IL-5) is a cytokine that regulates eosinophil biology and B-cell differentiation. Originally identified as a B-cell differentiation factor and T-cell replacing factor, IL-5 is primarily produced by activated T-helper 2 cells and serves as a key mediator in allergic and inflammatory responses. The cytokine promotes eosinophil development, activation, and survival, making it an important factor in asthma, allergic rhinitis, and other eosinophil-associated disorders. IL-5 also functions as an eosinophil differentiation factor, regulating the maturation and recruitment of these cells to sites of inflammation. This Human Interleukin-5 ELISA kit uses a quantitative sandwich measurement principle to detect IL-5 in serum, plasma, and tissue homogenates. The assay offers a detection range of 3.9 pg/ml to 250 pg/ml with a sensitivity of 0.97 pg/ml. The protocol requires 50-100 μl sample volume and can be completed within 1-5 hours. Detection occurs at 450 nm wavelength, providing researchers with a reliable tool for measuring human IL-5 levels in various biological samples. Application Examples Note: The following application examples are drawn from a selection of publications citing this product. For additional applications, please refer to the full list of references in the "Citations" section. This ELISA kit has been used in research examining inflammatory and immune responses, particularly in studies analyzing cytokine profiles in various disease contexts. The kit allows quantitative measurement of IL-5 in human biological samples, supporting research into eosinophil-mediated inflammatory processes and immune system dysregulation. Applications span from serum-based biomarker studies to tissue-based protein expression analysis. • Inflammatory biomarker research: Serum-based studies measuring IL-5 alongside other inflammatory cytokines to assess immune system activation and cytokine network interactions in disease states • Cytokine profiling studies: Multi-analyte studies examining various interleukins and immune mediators to characterize inflammatory responses and immune cell differentiation patterns • Tissue-based protein analysis: Quantification of IL-5 protein levels in tissue homogenates from esophageal samples, allowing assessment of local inflammatory responses in specific anatomical sites • Immune system research: Studies examining T-cell and B-cell mediated responses, particularly focusing on eosinophil differentiation and activation pathways in various pathological conditions
- Type I interferon (IFN)-dependent inhibition of T cell-derived IL-5 is mediated by IFN-alpha acting directly on activated T cells. PMID: 23382558
- Strong IL-5 production was detected in response to peptides from several of the previously undescribed proteins of grass pollen. PMID: 23401558
- When patients were classified according to sputum IgE levels, it appeared that IL-5, IL-6, IL-17 and TNF-alpha sputum supernatant levels were raised in the "IgE high" asthmatics when compared to "IgE low" asthmatics PMID: 23555579
- In activated eosinophils ligation of Siglec-8 leads to ROS-dependent enhancement of IL-5-induced ERK phosphorylation, which results in a novel mode of biochemically regulated eosinophil cell death. PMID: 23684072
- These unexpected results provide a theoretical basis for the therapeutic targeting of IL-5 in bladder cancer PMID: 23770289
- Patients with the 'IL-5, IL-17A, IL-25-high' airway inflammatory pattern are often uncontrolled asthmatics, despite daily treatment. PMID: 23957336
- Mechanisms of human eosinophil migration induced by the combination of IL-5 and the endocannabinoid 2-arachidonoyl-glycerol. PMID: 24530098
- Fibrocytes studied were generated in vitro from PBMCs by culturing in the presence of platelet derived growth factors and stimulated by IL-33. Fibrocytes constitutively expressed IL-13 and IL-5, which was augmented by stimulation with IL-33. PMID: 24822215
- HDM-specific IL-5 responses at age 3 years or later are the best measure of T cell function for predicting asthma at age 8 years. PMID: 24875149
- increased levels in recurrent versus nonrecurrent rhinosinusitis with nasal polyps at the moment of the first surgery PMID: 24980230
- Subsequent IL-5-stimulated signaling. PMID: 25121926
- IL-5 may be part of protective mechanisms operating in early atherosclerosis, at least in women PMID: 25587992
- Results showed that PAX2 expression is significantly overexpressed in esophageal squamous cell carcinoma tissues and IL-5 is identified as PAX2's effector for metastasis. PMID: 25613757
- Production of IL-5 in response to both extract and the Bet v1-derived peptide mix strongly suggested that T cells were a major source of IL-5. PMID: 25817862
- It has been shown in this study that the level of IL-5, one of the markers of eosinophilic inflammation, is higher in EBC of children with atopic asthma than in those with nonatopic asthma. PMID: 25937050
- Post-liver transplant patients with food allergy showed a unique cytokine profile in response to various stimuli, with extremely elevated IL-5, low IL-10 secretion. PMID: 26282695
- Data indicate that interleukin 5 (IL-5)-associated single nucleotide polymorphisms (SNPs) were not associated with carotid intima-media thickness. PMID: 26821299
- Interleukin-5/-targeted treatments offer promises to patients with eosinophilic respiratory disorders; review PMID: 26859368
- Serum IL-5 and IL-13 are reliable biomarkers for the blood eosinophilia asthma phenotype. PMID: 27060452
- simvastatin was demonstrated to inhibit IL-5-induced CCR3 expression and chemotaxis of eosinophils mediated via the mevalonate pathway. PMID: 27275740
- eosinophilia in FE is secondary to dysregulation of IL-5 production in PBMC (and their component subsets). PMID: 28226398
- Data indicate that interleukin-5 (IL-5) was that only serum cytokines show statistical significance between severe chronic obstructive pulmonary disease (COPD) and controls. PMID: 28398462
- Obesity alters the lung neutrophil infiltration to enhance breast cancer metastasis through IL5 and GM-CSF. PMID: 28737771
- Longitudinal co-variations between inflammatory cytokines, lung function and patient reported outcomes in patients with asthma PMID: 28915273
- IL-5 is expressed intrathecally in tick-borne encephalitis, but its pathogenetic role remains unclear. PMID: 29602685
Intra-assay Precision (Precision within an assay): CV%<8% | ||||||
Three samples of known concentration were tested twenty times on one plate to assess. | ||||||
Inter-assay Precision (Precision between assays): CV%<10% | ||||||
Three samples of known concentration were tested in twenty assays to assess. | ||||||
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed. | |||||||
| |||||||
pg/ml | OD1 | OD2 | Average | Corrected | |||
250 | 2.973 | 2.834 | 2.904 | 2.754 | |||
125 | 2.276 | 2.167 | 2.222 | 2.072 | |||
62.5 | 1.248 | 1.228 | 1.238 | 1.089 | |||
31.25 | 0.635 | 0.629 | 0.632 | 0.483 | |||
15.6 | 0.363 | 0.371 | 0.367 | 0.218 | |||
7.8 | 0.269 | 0.253 | 0.261 | 0.112 | |||
3.9 | 0.217 | 0.214 | 0.216 | 0.066 | |||
0 | 0.144 | 0.155 | 0.149 |
| |||
To assess the linearity of the assay, samples were spiked with high concentrations of human IL-5 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay. | ||||||
| Sample | Serum(n=4) | ||||
1:1 | Average % | 88 | ||||
Range % | 82-96 | |||||
1:2 | Average % | 92 | ||||
Range % | 90-105 | |||||
1:4 | Average % | 95 | ||||
Range % | 92-103 | |||||
1:8 | Average % | 90 | ||||
Range % | 86-98 | |||||
The recovery of human IL-5 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section. | ||||||
Sample Type | Average % Recovery | Range | ||||
Serum (n=5) | 85 | 80-92 | ||||
EDTA plasma (n=4) | 87 | 82-94 | ||||
MH Jabbar · / · 2023
Human Interleukin 5,IL-5 ELISA KIT | For research use only | Store 2-8°C | Diagnocine















